Gonzalez-Scarano F,Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5(1):69-81. doi:nri1527,10.1038/nri1527
Huang L, Crothers K, Atzori C, Benfield T, Miller R, Rabodonirina M, Helweg-Larsen J (2004) Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis 10(10):1721-1728
Rodriguez M, Fishman JA (2004) Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 17(4):770-782. doi:17/4/770,10.1128/CMR.17.4.770- 782.2004
Gangjee A, Kurup S, Namjoshi O (2007) Dihydrofolate reductase as a target for chemotherapy in parasites. Curr Pharm Des 13(6):609-639
Gangjee A, Guo X, Queener SF, Cody V, Galitsky N, Luft JR, Pangborn W (1998) Selective Pneumocystis carinii dihydrofolate reductase inhibitors: Design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted- furo[2,3-d]pyrimidines. J Med Chem 41(8):1263-1271. doi:10.1021/jm970537w, jm970537w
Graffner-Nordberg M, Kolmodin K, Aqvist J, Queener SF, Hallberg A (2001) Design, synthesis, computational prediction, and biological evaluation of ester soft drugs as inhibitors of dihydrofolate reductase from Pneumocystis carinii. J Med Chem 44(15):2391-2402. doi: Jm010856u
Gangjee A, Adair O, Queener SF (2001) Synthesis of 2,4-diamino-6- (thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors. Bioorg Med Chem 9(11):2929-2935. doi: S0968089601002231
Gangjee A, Adair OO, Pagley M, Queener SF (2008) N9-substituted 2,4-diaminoquinazolines: Synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase. J Med Chem 51 (19):6195-6200. doi:10.1021/jm800694g
Gangjee A, Adair OO, Queener SF (2003) Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. J Med Chem 46(23):5074-5082. doi:10.1021/jm030312n
Gangjee A, Vidwans AP, Vasudevan A, Queener SF, Kisliuk RL, Cody V, Li RM, Galitsky N, Luft JR, Pangborn S (1998) Structurebased design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents. J Med Chem 41 (18):3426-3434. doi:10.1021/jm980081y
Gangjee A, Adair O, Queener SF (1999) Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: Synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. J Med Chem 42(13):2447-2455. doi:10.1021/jm990079m,jm990079m
De Freitas GB, da Silva LL, Romeiro NC, Fraga CA (2009) Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors. Eur J Med Chem 44(6):2482-2496. doi:S0223-5234(09) 00020-8,10.1016/j.ejmech.2009.01.026
Kubinyi H, Folkers G, Martin YC (1998) 3D QSAR in drug design: Recent advances, vol 3. Three-dimensional quantitative structure activitity relationships. Kluwer, Dordrecht
Bartlett MS, Shaw M, Navaran P, Smith JW, Queener SF (1995) Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii. Antimicrob Agents Chemother 39(11):2436-2441
Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110(18):5959-5967. doi:10.1021/ja00226a005
Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37 (24):4130-4146
Cody V, Pace J, Chisum K, Rosowsky A (2006) New insights into DHFR interactions: Analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omegacarboxy (alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions. Proteins 65(4):959-969. doi:10.1002/prot.21131
Cody V, Galitsky N, Luft JR, Pangborn W, Queener SF, Gangjee A (2002) Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+and Pneumocystis carinii dihydrofolate reductase. Acta Crystallogr D Biol Crystallogr 58(Pt 9):1393-1399. doi:10.1107/S0907444902010442, S0907444902010442
Wavefunction Inc (2006) Spartan'06, Wavefunction Inc., 18401 Von Karman Avenue, Suite 370 Irvine, CA 92612, USA
HumphreyW, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics. J Mol Graph 14(1):33-38. doi:0263785596000185, 27-28
Cody V, Pace J (2011) Structural analysis of Pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent 6-[5'-(omega- carboxyalkoxy)benzyl]pyrido[2,3-d]pyrimidine derivatives. Acta Crystallogr D Biol Crystallogr 67(Pt 1):1-7. doi:10.1107/S0907444910041004
Tripos International (2008) SYBYL v.8.0, Tripos International, 1699 South Hanley Rd., St. Louis, MO
Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron 36(22):3219-3228
Efroymson MA (1960) Mathematical methods for digital computers. Multiple regression analysis. Wiley, New York
Gangjee A, Lin X (2005) CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase. J Med Chem 48(5):1448-1469. doi:10.1021/jm040153n
Barreiro EJ, Kummerle AE, Fraga CA (2011) The methylation effect in medicinal chemistry. Chem Rev 111(9):5215-5246. doi:10.1021/cr200060g
Thomas G (2003) Fundamental of medicinal chemsitry. Wiley, Chichester
